Dr. Russell Anthony Settipane, MD

Dr. Settipane practices at Allergy & Asthma Center Of Providence in East Providence, Rhode Island.

Dr. Settipane's NPI, 1053470476, was assigned on December 8, 2006. Dr. Settipane graduated from New York Medical College in 1984. Dr. Settipane holds Rhode Island license 6891.

Dr. Settipane's primary practice is Allergy & Asthma Center of Providence, at 450 Veterans Memorial Pkwy Bldg 15 Bldg 15, East Providence, RI 02914-5300. The practice phone is (401) 331-8426.

Dr. Settipane's primary practice is Allergy & Asthma Center Of Providence in East Providence, Rhode Island. Dr. Settipane is also affiliated with The Miriam Hospital. The medical group on file is Allergy and Asthma Centers of Rhode Island. Dmand AI also links Dr. Settipane to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Settipane practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Settipane's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Settipane is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Settipane's licenses on file in 2 states: Rhode Island and California.

Dmand AI lists asthma, chronic nasal allergies and hives among the conditions Dr. Settipane treats.

CMS data shows 3,657 Medicare services from Dr. Settipane across 10 procedure codes in 2024, for 229 Medicare patients. Medicare paid $45,729 for them. Every service was in an office.

CMS counts 229 Medicare patients who saw Dr. Settipane in 2024. The largest group is 65 to 74, with 118 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 0.83, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Settipane's median patient age at 42, with 60% women.

In 2024, Dr. Settipane wrote 1,727 Medicare Part D claims for 295 patients. 46% of them were for generic drugs. CMS names the drug for 1,577 of them, across 31 drugs with 11 or more claims each, at $835,239 in total drug cost. In 2023, CMS named 1,334 claims across 30 drugs.

Dr. Settipane accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 148 papers to Dr. Settipane, published from 2009 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Asthma, Hypersensitivity and Allergists. Dr. Settipane has published most often in Allergy Asthma Proc. Dr. Settipane's most frequent co-authors are Don A. Bukstein, MD, Anju T. Peters, MD and Jonathan A. Bernstein, MD.

Dmand AI links Dr. Settipane to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Asthma, Chronic Urticaria and Nasal Polyps. Open Payments lists research payments to Dr. Settipane that name 2 trials.

CMS Open Payments shows 2,717 general payments to Dr. Settipane from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. AstraZeneca Pharmaceuticals LP paid the most, $415,536. It also lists 20 research payments totaling $39,237 from 2016 to 2022, naming 2 clinical trials.

Dmand AI lists 5 awards for Dr. Settipane, most recently Regional Top Doctor in 2014.

Dr. Settipane graduated from New York Medical College in 1984. Dr. Settipane is a member of AAAAI, ACAAI, ACCP, ACP, AMA and ATS.

Dr. Settipane is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.